Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:24 am Sale | 2023-12-31 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | VIKING GLOBAL INVESTORS LP | 2,962,555 4.400% | -1,672,051 (-36.08%) | Filing History |
| 2024-02-14 10:23 am Unchanged | 2023-12-31 | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 20.700% | 0 (Unchanged) | Filing History |
| 2024-02-14 10:21 am Purchase | 2023-12-31 | 13G | TREVI THERAPEUTICS INC TRVI | VIKING GLOBAL INVESTORS LP | 6,599,062 9.990% | 436,700 (+7.09%) | Filing History |
| 2024-02-14 10:20 am Sale | 2023-12-31 | 13G | ROIVANT SCIENCES LTD SHS ROIV | VIKING GLOBAL INVESTORS LP | 69,368,961 8.600% | -5,869,739 (-7.80%) | Filing History |
| 2024-02-14 10:18 am Unchanged | 2023-12-31 | 13G | RALLYBIO CORP COM RLYB | VIKING GLOBAL INVESTORS LP | 524,347 11.100% | 0 (Unchanged) | Filing History |
| 2024-02-14 10:17 am Sale | 2023-12-31 | 13G | PEPGEN INC PEPG | VIKING GLOBAL INVESTORS LP | 1,482,434 6.200% | -62,197 (-4.03%) | Filing History |
| 2024-02-14 10:16 am Unchanged | 2023-12-31 | 13G | GINKGO BIOWORKS HOLDINGS INC C DNA | VIKING GLOBAL INVESTORS LP | 3,577,128 8.800% | 0 (Unchanged) | Filing History |
| 2024-02-14 10:15 am Sale | 2023-12-31 | 13G | VALVOLINE INC VVV | VIKING GLOBAL INVESTORS LP | 3,176,309 2.400% | -5,162,147 (-61.91%) | Filing History |
| 2024-02-14 10:13 am Sale | 2023-12-31 | 13G | VIKING THERAPEUTICS INC VKTX | VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% | -713,420 (-12.18%) | Filing History |
| 2024-02-14 10:12 am Purchase | 2023-12-31 | 13G | NEWAMSTERDAM PHARMA CO NV SHS NAMS | VIKING GLOBAL INVESTORS LP | 8,024,565 9.700% | 1,500,000 (+22.99%) | Filing History |
| 2024-02-14 10:11 am Sale | 2023-12-31 | 13G | FIVE9 INC FIVN | VIKING GLOBAL INVESTORS LP | 2,714,117 3.700% | -933,478 (-25.59%) | Filing History |
| 2024-02-14 10:00 am Purchase | 2023-12-31 | 13G | VERASTEM INC VSTM | VIKING GLOBAL INVESTORS LP | 2,531,829 9.990% | 1,211,173 (+91.71%) | Filing History |
| 2024-02-14 10:00 am Purchase | 2023-12-31 | 13G | INHIBRX INC INBX | VIKING GLOBAL INVESTORS LP | 7,150,826 15.100% | 511,627 (+7.71%) | Filing History |
| 2024-02-05 4:29 pm Unchanged | 2024-02-01 | 13D | CAZOO GROUP LTD OCT 2023 CZOOF | VIKING GLOBAL INVESTORS LP | 2,142,728 43.800% | 0 (Unchanged) | Filing History |
| 2024-01-30 4:31 pm Purchase | 2024-01-20 | 13G | ORIC PHARMACEUTICALS INC ORIC | VIKING GLOBAL INVESTORS LP | 4,000,000 5.900% | 4,000,000 (New Position) | Filing History |
| 2024-01-09 4:46 pm Purchase | 2024-01-05 | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 29,106,365 9.500% | 20,817,249 (+251.14%) | Filing History |
| 2024-01-08 4:15 pm Sale | 2024-01-04 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 4,247,914 9.900% | -540,000 (-11.28%) | Filing History |
| 2024-01-08 4:05 pm Purchase | 2023-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | VIKING GLOBAL INVESTORS LP | 4,787,914 11.200% | 850,000 (+21.59%) | Filing History |
| 2023-12-08 4:10 pm Purchase | 2023-12-06 | 13D | CAZOO GROUP LTD OCT 2023 CZOOF | VIKING GLOBAL INVESTORS LP | 2,142,728 43.800% | 2,112,728 (+7042.43%) | Filing History |
| 2023-11-22 4:15 pm Unchanged | 2023-10-04 | 13D | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,289,116 9.500% | 0 (Unchanged) | Filing History |